SOX6 and central nervous system cancer: Schlierf et al. 10 and Ueda et al. 11 found that during the early stage of gliomagenesis, SOX6 acts as an oncoprotein that induces the enhancement of transcriptional regulation, leading to high levels of SOX6 in the tissues and sera of patients with glioma.